Oarsman Capital, Inc. Merck & Co., Inc. Transaction History

Oarsman Capital, Inc.

$533 Million
Q3 2024

A detailed history of Oarsman Capital, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Oarsman Capital, Inc. holds 2,787 shares of MRK stock, worth $276,414. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,787

Previous 2,501 11.44%

Holding current value

$276,414

Previous $309,000 2.27%

% of portfolio

0.06%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$111.15 - $128.97 $31,788 - $36,885	286 Added 11.44%	2,787 $316,000
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $28,597 - $30,713	231 Added 10.18%	2,501 $309,000
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $13,135 - $15,306	116 Added 5.39%	2,270 $299,000
Q4 2023 Feb 16, 2024	BUY	$100.18 - $109.02 $215,787 - $234,829	2,154 New	2,154 $234,000
Q2 2022 Aug 10, 2022	SELL	$83.49 - $94.64 $223,920 - $253,824	-2,682 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $197,153 - $220,996	2,682 New	2,682 $220,000
Q4 2021 Feb 10, 2022	SELL	$72.28 - $90.54 $233,970 - $293,077	-3,237 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$68.86 - $81.11 $3,443 - $4,055	-50 Reduced 1.52%	3,237 $250,000
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $717 - $796	10 Added 0.31%	3,287 $269,000
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $365 - $414	-5 Reduced 0.15%	3,277 $272,000
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $231,118 - $262,986	3,282 New	3,282 $254,000
Q1 2020 May 13, 2020	SELL	$63.36 - $87.82 $220,682 - $305,877	-3,483 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $10,007 - $11,292	129 Added 3.85%	3,483 $317,000
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $8,749 - $9,536	115 Added 3.55%	3,354 $282,000
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $1,396 - $1,631	-20 Reduced 0.61%	3,239 $272,000
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $3,479 - $3,968	-50 Reduced 1.51%	3,259 $271,000
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $6,850 - $7,949	-105 Reduced 3.08%	3,309 $253,000
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $173,533 - $203,884	3,414 New	3,414 $207,000
Q4 2017 Feb 08, 2018	SELL	$51.62 - $61.64 $176,127 - $210,315	-3,412 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $200,182 - $215,399	3,412	3,412 $218,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.

Account

Oarsman Capital, Inc. Merck & Co., Inc. Transaction History